Foxp3 + regulatory T cells, immune stimulation and host defence against infection

Immunology

Volumn 136, Issue 1, 2012, Pages 1-10

  Rowe, Jared H ^a   Ertelt, James M ^a   Way, Sing Sing ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Infection; Regulatory T cells; T cell activation; Tolerance; Vaccination

Indexed keywords

CYTOKINE; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR ALPHA; T LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR FOXP3;

CANDIDIASIS; CD4+ T LYMPHOCYTE; HOST RESISTANCE; IN VIVO STUDY; INFECTION; LEISHMANIASIS; LISTERIOSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; REVIEW; SALMONELLOSIS; TOXOPLASMOSIS; TRANSGENIC MOUSE; TUBERCULOSIS; WEST NILE FLAVIVIRUS;

ANIMALS; BACTERIAL INFECTIONS; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; IMMUNE TOLERANCE; T-LYMPHOCYTES, REGULATORY; VIRUS DISEASES;

EID: 84859316999     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/j.1365-2567.2011.03551.x     Document Type: Review

References (102)

1. + regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol 2004; 22:531-62.
2. Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 1995; 155:1151-64.
3. + T cells inhibit both the induction and effector function of autoreactive T cells and represent a unique lineage of immunoregulatory cells. J Immunol 1998; 160:1212-8.
4. + regulatory T cells. Nat Immunol 2003; 4:330-6.
5. Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science (New York, NY) 2003; 299:1057-61.
6. + T regulatory cells. Nat Immunol 2003; 4:337-42.
7. Bennett CL, Christie J, Ramsdell F et al. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat Genet 2001; 27:20-1.
8. Wildin RS, Ramsdell F, Peake J et al. X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nat Genet 2001; 27:18-20.
9. Ochs HD, Gambineri E, Torgerson TR. IPEX, FOXP3 and regulatory T-cells: a model for autoimmunity. Immunol Res 2007; 38:112-21.
10. Brunkow ME, Jeffery EW, Hjerrild KA et al. Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat Genet 2001; 27:68-73.
11. + regulatory T cells control Leishmania major persistence and immunity. Nature 2002; 420:502-7.
12. Kursar M, Koch M, Mittrucker HW, Nouailles G, Bonhagen K, Kamradt T, Kaufmann SH. Cutting edge: regulatory T cells prevent efficient clearance of Mycobacterium tuberculosis. J Immunol 2007; 178:2661-5.
13. + T cell responses. J Exp Med 2003; 198:889-901.
14. + regulatory T cells control the severity of viral immunoinflammatory lesions. J Immunol 2004; 172:4123-32.
15. + CD4 regulatory T cells limit pulmonary immunopathology by modulating the CD8 T cell response during respiratory syncytial virus infection. J Immunol 2010; 185:2382-92.
16. + regulatory T cells modulate the T-cell and antibody responses in Helicobacter-infected BALB/c mice. Infect Immun 2006; 74:3519-29.
17. Netea MG, Sutmuller R, Hermann C et al. Toll-like receptor 2 suppresses immunity against Candida albicans through induction of IL-10 and regulatory T cells. J Immunol 2004; 172:3712-8.
18. Taylor JJ, Mohrs M, Pearce EJ. Regulatory T cell responses develop in parallel to Th responses and control the magnitude and phenotype of the Th effector population. J Immunol 2006; 176:5839-47.
19. + regulatory T cells inhibit protective immunity to filarial parasites in vivo. J Immunol 2007; 179:4626-34.
20. + regulatory T cell responses during Friend retrovirus infection. Eur J Immunol 2006; 36:2658-70.
21. Belkaid Y. Regulatory T cells and infection: a dangerous necessity. Nat Rev 2007; 7:875-88.
22. Lund JM, Hsing L, Pham TT, Rudensky AY. Coordination of early protective immunity to viral infection by regulatory T cells. Science (New York, NY) 2008; 320:1220-4.
23. Lanteri MC, O'Brien KM, Purtha WE et al. Tregs control the development of symptomatic West Nile virus infection in humans and mice. J Clin Investig 2009; 119:3266-77.
24. high regulatory T cells in acute dengue infection. J Exp Med 2007; 204:979-85.
25. + natural regulatory T cells prevent experimental cerebral malaria via CTLA-4 when expanded in vivo. PLoS Pathog 2010; 6:e1001221.
26. Minigo G, Woodberry T, Piera KA et al. Parasite-dependent expansion of TNF receptor II-positive regulatory T cells with enhanced suppressive activity in adults with severe malaria. PLoS Pathog 2009; 5:e1000402.
27. Walther M, Jeffries D, Finney OC et al. Distinct roles for FOXP3 and FOXP3 CD4 T cells in regulating cellular immunity to uncomplicated and severe Plasmodium falciparum malaria. PLoS Pathog 2009; 5:e1000364.
28. + regulatory T cells correlates with more rapid parasite growth in human malaria infection. Immunity 2005; 23:287-96.
29. Torcia MG, Santarlasci V, Cosmi L et al. Functional deficit of T regulatory cells in Fulani, an ethnic group with low susceptibility to Plasmodium falciparum malaria. Proc Natl Acad Sci U S A 2008; 105:646-51.
30. Hansen DS, Schofield L. Natural regulatory T cells in malaria: host or parasite allies? PLoS Pathog 2010; 6:e1000771.
31. + regulatory T cells in the control of experimental cerebral malaria. J Immunol 2009; 183:7014-22.
32. + Treg cell number and acquisition of effector cell phenotype during lethal infection. Immunity 2009; 31:772-86.
33. + regulatory T cells promote Th17 cells in vitro and enhance host resistance in mouse Candida albicans Th17 cell infection model. Immunity 2011; 34:422-34.
34. Aluvihare VR, Kallikourdis M, Betz AG. Regulatory T cells mediate maternal tolerance to the fetus. Nat Immunol 2004; 5:266-71.
35. Kahn DA, Baltimore D. Pregnancy induces a fetal antigen-specific maternal T regulatory cell response that contributes to tolerance. Proc Natl Acad Sci U S A 2010; 107:9299-304.
36. + regulatory T cell expansion required for sustaining pregnancy compromises host defense against prenatal bacterial pathogens. Cell Host Microbe 2011; 10:54-64.
37. Gellin BG, Broome CV, Bibb WF, Weaver RE, Gaventa S, Mascola L. The epidemiology of listeriosis in the United States-1986. Listeriosis Study Group. Am J Epidemiol 1991; 133:392-401.
38. Mylonakis E, Paliou M, Hohmann EL, Calderwood SB, Wing EJ. Listeriosis during pregnancy: a case series and review of 222 cases. Medicine 2002; 81:260-9.
39. Pejcic-Karapetrovic B, Gurnani K, Russell MS, Finlay BB, Sad S, Krishnan L. Pregnancy impairs the innate immune resistance to Salmonella typhimurium leading to rapid fatal infection. J Immunol 2007; 179:6088-96.
40. Periasamy S, Singh A, Sahay B, Rahman T, Feustel PJ, Pham GH, Gosselin EJ, Sellati TJ. Development of tolerogenic dendritic cells and regulatory T cells favors exponential bacterial growth and survival during early respiratory tularemia. J Leukoc Biol 2011; 90:493-507.
41. + memory T cells. J Immunol 2003; 171:5853-64.
42. Bakardjiev AI, Theriot JA, Portnoy DA. Listeria monocytogenes traffics from maternal organs to the placenta and back. PLoS Pathog 2006; 2:e66.
43. Le Monnier A, Autret N, Join-Lambert OF, Jaubert F, Charbit A, Berche P, Kayal S. ActA is required for crossing of the fetoplacental barrier by Listeria monocytogenes. Infect Immun 2007; 75:950-7.
44. high regulatory T cells increases with age. Clin Exp Immunol 2005; 140:540-6.
45. high regulatory T cells are not impaired in patients with primary Sjögren's syndrome. J Autoimmun 2005; 24:235-42.
46. Sharma S, Dominguez AL, Lustgarten J. High accumulation of T regulatory cells prevents the activation of immune responses in aged animals. J Immunol 2006; 177:8348-55.
47. Lages CS, Suffia I, Velilla PA, Huang B, Warshaw G, Hildeman DA, Belkaid Y, Chougnet C. Functional regulatory T cells accumulate in aged hosts and promote chronic infectious disease reactivation. J Immunol 2008; 181:1835-48.
48. Gillespie IA, McLauchlin J, Grant KA, Little CL, Mithani V, Penman C, Lane C, Regan M. Changing pattern of human listeriosis, England and Wales, 2001-2004. Emerg Infect Dis 2006; 12:1361-6.
49. Brown JA, Factor DL, Tkachenko N et al. West Nile viremic blood donors and risk factors for subsequent West Nile fever. Vector Borne Zoonotic Dis 2007; 7:479-88.
50. O'Leary DR, Marfin AA, Montgomery SP et al. The epidemic of West Nile virus in the United States, 2002. Vector Borne Zoonotic Dis 2004; 4:61-70.
51. Sakaguchi S, Wing K, Onishi Y, Prieto-Martin P, Yamaguchi T. Regulatory T cells: how do they suppress immune responses? Int Immunol 2009; 21:1105-11.
52. + T regulatory cell-mediated suppression. Immunity 2009; 30:636-45.
53. Vignali DA, Collison LW, Workman CJ. How regulatory T cells work. Nat Rev 2008; 8:523-32.
54. Wing K, Sakaguchi S. Regulatory T cells exert checks and balances on self tolerance and autoimmunity. Nat Immunol 2010; 11:7-13.
55. + regulatory T cells require CTLA-4 for the maintenance of systemic tolerance. J Exp Med 2009; 206:421-34.
56. + regulatory T cell function. Science (New York, NY) 2008; 322:271-5.
57. Rubtsov YP, Rasmussen JP, Chi EY et al. Regulatory T cell-derived interleukin-10 limits inflammation at environmental interfaces. Immunity 2008; 28:546-58.
58. Scott-Browne JP, Shafiani S, Tucker-Heard G, Ishida-Tsubota K, Fontenot JD, Rudensky AY, Bevan MJ, Urdahl KB. Expansion and function of Foxp3-expressing T regulatory cells during tuberculosis. J Exp Med 2007; 204:2159-69.
59. Johanns TM, Ertelt JM, Rowe JH, Way SS. Regulatory T cell suppressive potency dictates the balance between bacterial proliferation and clearance during persistent Salmonella infection. PLoS Pathog 2010; 6:e1001043.
60. + regulatory T cells in reactivation of persistent leishmaniasis and control of concomitant immunity. J Exp Med 2004; 200:201-10.
61. Uzonna JE, Wei G, Yurkowski D, Bretscher P. Immune elimination of Leishmania major in mice: implications for immune memory, vaccination, and reactivation disease. J Immunol 2001; 167:6967-74.
62. Koch MA, Tucker-Heard G, Perdue NR, Killebrew JR, Urdahl KB, Campbell DJ. The transcription factor T-bet controls regulatory T cell homeostasis and function during type 1 inflammation. Nat Immunol 2009; 10:595-602.
63. H2 responses. Nature 2009; 458:351-6.
64. + regulatory T cells control TH17 responses in a Stat3-dependent manner. Science (New York, NY) 2009; 326:986-91.
65. + follicular regulatory T cells control the germinal center response. Nat Med 2011; 17:975-82.
66. Chung Y, Tanaka S, Chu F et al. Follicular regulatory T cells expressing Foxp3 and Bcl-6 suppress germinal center reactions. Nat Med 2011; 17:983-8.
67. + regulatory T cell fate during inflammation in mice. J Clin Investig 2011; 121:4503-15.
68. + cells. Eur J Immunol 2009; 39:3066-77.
69. + natural regulatory T cells are specific for microbial antigens. J Exp Med 2006; 203:777-88.
70. Shafiani S, Tucker-Heard G, Kariyone A, Takatsu K, Urdahl KB. Pathogen-specific regulatory T cells delay the arrival of effector T cells in the lung during early tuberculosis. J Exp Med 2010; 207:1409-20.
71. + T reg cells in the central nervous system during encephalomyelitis. J Exp Med 2011; 208:1571-7.
72. + T cells during Listeria monocytogenes infection. J Immunol 2009; 182:3032-8.
73. Antunes I, Tolaini M, Kissenpfennig A, Iwashiro M, Kuribayashi K, Malissen B, Hasenkrug K, Kassiotis G. Retrovirus-specificity of regulatory T cells is neither present nor required in preventing retrovirus-induced bone marrow immune pathology. Immunity 2008; 29:782-94.
74. Lathrop SK, Bloom SM, Rao SM et al. Peripheral education of the immune system by colonic commensal microbiota. Nature 2011; 478:250-4.
75. Moon JJ, Chu HH, Hataye J, Pagan AJ, Pepper M, McLachlan JB, Zell T, Jenkins MK. Tracking epitope-specific T cells. Nat Protoc 2009; 4:565-81.
76. + T cells. Curr Opin Immunol 2009; 21:281-5.
77. Zhou X, Bailey-Bucktrout SL, Jeker LT et al. Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivo. Nat Immunol 2009; 10:1000-7.
78. + T cell-mediated suppression by dendritic cells. Science (New York, NY) 2003; 299:1033-6.
79. + naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state. Int Immunol 1998; 10:1969-80.
80. + immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J Exp Med 1998; 188:287-96.
81. Kubo T, Hatton RD, Oliver J, Liu X, Elson CO, Weaver CT. Regulatory T cell suppression and anergy are differentially regulated by proinflammatory cytokines produced by TLR-activated dendritic cells. J Immunol 2004; 173:7249-58.
82. + regulatory T cells. Proc Natl Acad Sci U S A 2006; 103:7048-53.
83. Sutmuller RP, den Brok MH, Kramer M et al. Toll-like receptor 2 controls expansion and function of regulatory T cells. J Clin Investig 2006; 116:485-94.
84. + regulatory T cell function. Science (New York, NY) 2005; 309:1380-4.
85. Caramalho I, Lopes-Carvalho T, Ostler D, Zelenay S, Haury M, Demengeot J. Regulatory T cells selectively express toll-like receptors and are activated by lipopolysaccharide. J Exp Med 2003; 197:403-11.
86. + T regulatory cells. J Immunol 2005; 175:8051-9.
87. Fontenot JD, Rasmussen JP, Williams LM, Dooley JL, Farr AG, Rudensky AY. Regulatory T cell lineage specification by the forkhead transcription factor foxp3. Immunity 2005; 22:329-41.
88. + T cells. J Immunol 2011; 187:2569-77.
89. Wang RF, Peng G, Wang HY. Regulatory T cells and Toll-like receptors in tumor immunity. Semin Immunol 2006; 18:136-42.
90. van Duin D, Medzhitov R, Shaw AC. Triggering TLR signaling in vaccination. Trends Immunol 2006; 27:49-55.
91. + T cell effector pool size via IL-2 restriction. J Immunol 2011; 187:3186-97.
92. + T cell responses. J Exp Med 2002; 196:1585-92.
93. Moore AC, Gallimore A, Draper SJ, Watkins KR, Gilbert SC, Hill AV. Anti-CD25 antibody enhancement of vaccine-induced immunogenicity: increased durable cellular immunity with reduced immunodominance. J Immunol 2005; 175:7264-73.
94. + T-cell responses against herpes simplex virus type 1. J Virol 2004; 78:13082-9.
95. Curtsinger JM, Mescher MF. Inflammatory cytokines as a third signal for T cell activation. Curr Opin Immunol 2010; 22:333-40.
96. + T-cell IL-17 production. Immunology 2010; 131:183-91.
97. + T cell response. Immunity 2006; 25:19-29.
98. Kastenmuller K, Wille-Reece U, Lindsay RW et al. Protective T cell immunity in mice following protein-TLR7/8 agonist-conjugate immunization requires aggregation, type I IFN, and multiple DC subsets. J Clin Investig 2011; 121:1782-96.
99. Bousso P, Albert ML. Signal 0 for guided priming of CTLs: NKT cells do it too. Nat Immunol 2010; 11:284-6.
100. Mays LE, Wilson JM. The complex and evolving story of T cell activation to AAV vector-encoded transgene products. Mol Ther 2011; 19:16-27.
101. Brunstein CG, Miller JS, Cao Q et al. Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics. Blood 2011; 117:1061-70.
102. Hippen KL, Merkel SC, Schirm DK et al. Massive ex vivo expansion of human natural regulatory T cells (Tregs) with minimal loss of in vivo functional activity. Sci Transl Med 2011; 3:83ra41.